Galaxy银河|澳门官网·登录入口

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Antagonism of STAT1 by Nipah virus P gene products modulates disease course but not lethal outcome in the ferret model.

Sci Rep. 2019; 
Satterfield Benjamin A,Borisevich Viktoriya,Foster Stephanie L,Rodriguez Sergio E,Cross Robert W,Fenton Karla A,Agans Krystle N,Basler Christopher F,Geisbert Thomas W,Mire Ch
Products/Services Used Details Operation
Catalog Antibody The antisera were produced by GenScript (Piscataway, NJ) as described previously20 diluted in TTBS with 5% milk (P: 1:5,000; V: 1:500; W: 1:500) for 1 hour at room temperature, and washed 4 times in TTBS.  Get A Quote

摘要

Nipah virus (NiV) is a pathogenic paramyxovirus and zoononis with very high human fatality rates. Previous protein over-expression studies have shown that various mutations to the common N-terminal STAT1-binding motif of the NiV P, V, and W proteins affected the STAT1-binding ability of these proteins thus interfering with he JAK/STAT pathway and reducing their ability to inhibit type-I IFN signaling, but due to differing techniques it was unclear which amino acids were most important in this interaction or what impact this had on pathogenesis in vivo. We compared all previously described mutations in parallel and found the amino acid mutation Y116E demonstrated the greatest reduction in binding to STAT1 ... More

关键词

XML 地图